Suspected cardiac toxicity to intravenous immunoglobulin used for treatment of scleromyxedema.
Indian J Dermatol Venereol Leprol
;
2008 May-Jun; 74(3): 248-50
Article
in English
| IMSEAR
| ID: sea-52857
ABSTRACT
Scleromyxedema is a rare, generalized form of lichen myxedematosus, which may be associated with systemic involvement and can be fatal. The therapeutic options available provide partial or inconsistent response and are associated with significant adverse effects. We report a case of scleromyxedema with cardiac involvement, treated with low-dose intravenous immunoglobulin, with almost complete clearing of the skin lesions. The patient died after three cycles of treatment, possibly due to myocardial infarction.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Humans
/
Male
/
Risk Factors
/
Immunoglobulins, Intravenous
/
Death, Sudden, Cardiac
/
Fatal Outcome
/
Adult
/
Electrocardiography
/
Scleromyxedema
/
Heart Diseases
Type of study:
Etiology study
/
Risk factors
Language:
English
Journal:
Indian J Dermatol Venereol Leprol
Year:
2008
Type:
Article
Similar
MEDLINE
...
LILACS
LIS